BioNTech: The Leap from Personalized Can

Europe · Healthcare / Elderly Care · Founder Journeys

BioNTech: The Leap from Personalized Can Europe · Healthcare / Elderly Care · Founder Journeys 01 / 发家路径 02 / 失败与拐点 03 / 关键数据 起步 探索 增长 COVID-19… · 2020 · 发家路径 › 起步 COVID-19… 2020 Founding · 2008 · 发家路径 › 探索 Founding 2008 Partners… · 2018 · 发家路径 › 增长 Partners… 2018 核心数据 · 2021 Reven… · 关键数据 › 起步 核心数据 2021 Reven… Legend User UI Agent logic Policy Tool action Context / trace

失败与踩坑

  • • Failing to bring any self-developed prod…
  • • Being surpassed by Moderna in personaliz…
  • • The extreme and painful cost of single-p…

关键成功要素

  • • The oncology and immunology backgrounds …
  • • Pfizer's joint development agreement ena…
  • • The approximately 19 billion euros in re…
  • • The R&D capability for personalized neoa…

经验教训

  • • When a company's valuation is deeply tie…
  • • Extraordinary windfalls from public heal…
  • • After losing the first-mover advantage i…